Nishla Keiser — Senior VP & Deputy General Counsel at Intellia Therapeutics | Comparably
Intellia Therapeutics Claimed Company
Intellia Therapeutics is a leading genome editing company focused on developing proprietary, curative therapeutics using the CRISPR/Cas9 system. Intellia believes the CRISPR/Cas9 technology has the potential to transform medicine by permanently editing disease-associated genes in the human body with a single treatment course, and through improved cell therapies that can treat cancer and immunological diseases, or can replace patients’ diseased cells. The combination of deep scientific, technical and clinical development experience, along with its leading intellectual property portfolio, puts Intellia in a unique position to unlock broad therapeutic applications of the CRISPR/Cas9 technology and create a new class of therapeutic products. read more
EMPLOYEE
PARTICIPANTS
12
TOTAL
RATINGS
170
HR or Marketing? Claim Your Free Employer Account
Nishla Keiser — Senior VP & Deputy General Counsel at Intellia Therapeutics

Nishla Keiser — Senior VP & Deputy General Counsel at Intellia Therapeutics

Executive Bio

Ms. Nishla Keiser has been Senior Vice President and Deputy General Counsel at Intellia Therapeutics Inc. since November 3, 2017. Ms. Keiser has been working with biotechnology and pharmaceutical companies since 2004, building extensive experience in intellectual property strategy, management and litigation in technologies ranging from nucleic acid and protein therapeutics, small molecules, formulations, analytics and medical devices. She was an attorney at a leading global intellectual property law firm, where she worked on patent litigation to protect multiple branded pharmaceutical products and strategic IP counseling for biotechnology and pharmaceutical companies ranging from start-up companies to large corporations. At Intellia, she focuses on developing and implementing Intellia's internal and external IP strategies, as well as general regulatory, compliance and corporate legal matters. She received her Bachelor of Science degrees in Biology, Chemistry and Chemical Engineering, a

Executive Team Culture Ratings from Intellia Therapeutics Employees

TOP
30%
Intellia Therapeutics' Executive Team scores in the Top 30%
of similar sized companies on Comparably
Who ranks the Executive Team the highest?
Not Enough Ratings To Show Who Ranks Executive Team the Highest
Anonymously rate my experience at Intellia Therapeutics
Who ranks the Executive Team the lowest?
Not Enough Ratings To Show Who Ranks Executive Team the Lowest
Anonymously rate my experience at Intellia Therapeutics

Intellia Therapeutics' Executive Team at a Glance

Based on 10 ratings, Intellia Therapeutics' employees are satisfied with their Executive Team and give them a ā€œBā€ or 73/100.

Intellia Therapeutics' Executive Team ranks in the Top 35% of other companies in Boston and Top 30% of other companies on Comparably that also have 201-500 Employees.

×
Rate your company